Procaps Group S.A. (NASDAQ: PROC)
$0.7141
+0.1430 ( +21.03% ) 33.6K
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
Market Data
Open
$0.7141
Previous close
$0.5715
Volume
33.6K
Market cap
$75.59M
Day range
$0.5400 - $0.7470
52 week range
$0.5000 - $4.9500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 3 | May 14, 2024 |
| 6-k | Form 6-K | 3 | May 01, 2024 |
| nt | Quarterly Reports | 1 | May 01, 2024 |
| 6-k | Form 6-K | 4 | Mar 04, 2024 |
| 6-k | Form 6-K | 1 | Jan 24, 2024 |
| 6-k | Form 6-K | 3 | Jan 16, 2024 |
| 6-k | Form 6-K | 6 | Jan 05, 2024 |
| 6-k | Form 6-K | 5 | Dec 26, 2023 |
| 6-k | Form 6-K | 4 | Dec 26, 2023 |
| 6-k | Form 6-K | 3 | Nov 22, 2023 |